.webp)
67/100B67.290
USD
-0.26
(-0.38%)
Post Trading·68.800USD+1.510(+2.24%)
Last updated: · Delayed 15 min
Fair value63.11Plus+7%48Price 67.2994
Q4 FY2026 · Earnings report
EPS estimate 1.53Revenue estimate 960.74M
Q4 FY2026 · Earnings report
EPS estimate 1.53Revenue estimate 960.74M
Royalty Pharma dividend yieldWhat is dividend yield? Dividend yield is a year of dividends as a percentage of the share price: the income a shareholder receives for each dollar invested at today's price.
Royalty Pharma's dividend yield is 1.36%: it pays 0.94 a share a year at today's price of 67.29.
- Today
- 1.36%
- Average, 5 years
- 2.33%
- Low, 5 years
- 1.39%
- High, 5 years
- 3.46%
Dividend yield = dividends paid (last 12 months) ÷ market cap = 408.87M ÷ 29.96B = 1.36%
Each day's dividend at its yearly rate (the latest dividend times the payments a year) over that day's closing price.
Dividend yield by year and by quarter
| Fiscal year | Period ending | Dividend yield | Dividends paid | Market cap |
|---|---|---|---|---|
| Today | 1.36% | 408.87M | 29.96B | |
| FY2025 | 31 Dec 2025 | 2.27% | 378.25M | 16.69B |
| FY2024 | 31 Dec 2024 | 3.31% | 376.47M | 11.38B |
| FY2023 | 31 Dec 2023 | 2.85% | 358.33M | 12.57B |
| FY2022 | 31 Dec 2022 | 1.93% | 333.32M | 17.31B |
| FY2021 | 31 Dec 2021 | 1.73% | 285.18M | 16.53B |
| FY2020 | 31 Dec 2020 | 2.05% | 397.84M | 19.43B |
| FY2019 | 31 Dec 2019 | 4.69% | 739.28M | 15.76B |
| FY2018 | 31 Dec 2018 | 5.17% | 814.36M | 15.76B |
| FY2017 | 31 Dec 2017 | 4.66% | 735.17M | 15.76B |
| FY2016 | 31 Dec 2016 | — | — | 27.01B |
| FY2015 | 31 Dec 2015 | — | — | 27.01B |
| Quarter | Period ending | Dividend yield | Dividends paid | Market cap |
|---|---|---|---|---|
| Q3 FY2026 | 30 Sept 2026 | 1.57% | 408.87M | 25.97B |
| Q2 FY2026 | 30 Jun 2026 | 1.60% | 399.06M | 24.95B |
| Q1 FY2026 | 31 Mar 2026 | 1.87% | 387.39M | 20.72B |
| Q4 FY2025 | 31 Dec 2025 | 2.27% | 378.25M | 16.69B |
| Q3 FY2025 | 30 Sept 2025 | 2.48% | 377.57M | 15.24B |
| Q2 FY2025 | 30 Jun 2025 | 2.47% | 376.32M | 15.26B |
| Q1 FY2025 | 31 Mar 2025 | 2.79% | 378.02M | 13.56B |
| Q4 FY2024 | 31 Dec 2024 | 3.31% | 376.47M | 11.38B |
| Q3 FY2024 | 30 Sept 2024 | 2.95% | 372.15M | 12.62B |
| Q2 FY2024 | 30 Jun 2024 | 3.11% | 367.84M | 11.81B |
| Q1 FY2024 | 31 Mar 2024 | 2.71% | 363.50M | 13.41B |
| Q4 FY2023 | 31 Dec 2023 | 2.85% | 358.33M | 12.58B |
| Q3 FY2023 | 30 Sept 2023 | 2.90% | 353.19M | 12.17B |
| Q2 FY2023 | 30 Jun 2023 | 2.51% | 347.25M | 13.85B |
| Q1 FY2023 | 31 Mar 2023 | 2.12% | 339.69M | 16.06B |
| Q4 FY2022 | 31 Dec 2022 | 1.91% | 333.32M | 17.46B |
| Q3 FY2022 | 30 Sept 2022 | 1.83% | 322.72M | 17.65B |
| Q2 FY2022 | 30 Jun 2022 | 1.70% | 311.93M | 18.34B |
| Q1 FY2022 | 31 Mar 2022 | 1.78% | 301.46M | 16.91B |
| Q4 FY2021 | 31 Dec 2021 | 1.70% | 285.18M | 16.80B |
| Q3 FY2021 | 30 Sept 2021 | 1.74% | 269.19M | 15.48B |
| Q2 FY2021 | 30 Jun 2021 | 1.50% | 251.05M | 16.78B |
| Q1 FY2021 | 31 Mar 2021 | 1.89% | 322.05M | 17.00B |
| Q4 FY2020 | 31 Dec 2020 | 2.05% | 397.84M | 19.43B |
| Q3 FY2020 | 30 Sept 2020 | 3.31% | 515.48M | 15.57B |
| Q2 FY2020 | 30 Jun 2020 | 3.66% | 628.58M | 17.19B |
| Q1 FY2020 | 31 Mar 2020 | 4.38% | 683.38M | 15.60B |
| Q4 FY2019 | 31 Dec 2019 | 4.71% | 739.28M | 15.68B |
| Q3 FY2019 | 30 Sept 2019 | — | — | 15.76B |
| Q2 FY2019 | 30 Jun 2019 | — | — | 15.76B |
| Q1 FY2019 | 31 Mar 2019 | — | — | 15.76B |
Figures in USD. A quarter's revenue, net income and dividends are those of its last four quarters.
See also:P/E ratio,Market cap,P/S ratio,Debt to equity,Current ratio,All ratios
Common questions about Royalty Pharma's dividend yield
Source: Financial Modeling Prep